Literature DB >> 34426949

Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia.

Christine Le1, Elizabeth Finger2.   

Abstract

Despite significant progress in the understanding of the frontotemporal dementias (FTDs), there remains no disease-modifying treatment for these conditions, and limited effective symptomatic treatment. Behavioural variant frontotemporal dementia (bvFTD) is the most common FTD syndrome, and is characterized by severe impairments in behaviour, personality and cognition. Neuropsychiatric symptoms are common features of bvFTD but are present in the other FTD syndromes. Current treatment strategies therefore focus on ameliorating the neuropsychiatric features. Here we review the rationale for current treatments related to each of the main neuropsychiatric symptoms forming the diagnostic criteria for bvFTD relevant to all FTD subtypes, and two additional symptoms not currently part of the diagnostic criteria: lack of insight and psychosis. Given the paucity of effective treatments for these symptoms, we highlight how contributing mechanisms delineated in cognitive neuroscience may inform future approaches to clinical trials and more precise symptomatic treatments for FTDs.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34426949     DOI: 10.1007/s40263-021-00854-5

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  170 in total

Review 1.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

2.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia.

Authors:  J S Snowden; D Bathgate; A Varma; A Blackshaw; Z C Gibbons; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

3.  Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution.

Authors:  William W Seeley; John M Allman; Danielle A Carlin; Richard K Crawford; Marcelo N Macedo; Michael D Greicius; Stephen J Dearmond; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

4.  Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration.

Authors:  Kamalini G Ranasinghe; Katherine P Rankin; Peter S Pressman; David C Perry; Iryna V Lobach; William W Seeley; Giovanni Coppola; Anna M Karydas; Lea T Grinberg; Tal Shany-Ur; Suzee E Lee; Gil D Rabinovici; Howard J Rosen; Maria Luisa Gorno-Tempini; Adam L Boxer; Zachary A Miller; Winston Chiong; Mary DeMay; Joel H Kramer; Katherine L Possin; Virginia E Sturm; Brianne M Bettcher; Michael Neylan; Diana D Zackey; Lauren A Nguyen; Robin Ketelle; Nikolas Block; Teresa Q Wu; Alison Dallich; Natanya Russek; Alyssa Caplan; Daniel H Geschwind; Keith A Vossel; Bruce L Miller
Journal:  JAMA Neurol       Date:  2016-09-01       Impact factor: 18.302

Review 5.  Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Davide Seripa; Antonio Daniele; Mark Watling; Gianluigi Giannelli
Journal:  Nat Rev Neurol       Date:  2020-03-23       Impact factor: 42.937

Review 6.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

7.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Authors:  Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

Review 8.  Frontotemporal dementia (Pick's disease): clinical features and assessment.

Authors:  J R Hodges
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

9.  Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS.

Authors:  Howard J Rosen; Bradley F Boeve; Adam L Boxer
Journal:  Alzheimers Dement       Date:  2020-01       Impact factor: 21.566

10.  Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia.

Authors:  Alberto Benussi; Enrico Premi; Stefano Gazzina; Chiara Brattini; Elisa Bonomi; Antonella Alberici; Lize Jiskoot; John C van Swieten; Raquel Sanchez-Valle; Fermin Moreno; Robert Laforce; Caroline Graff; Matthis Synofzik; Daniela Galimberti; Mario Masellis; Carmela Tartaglia; James B Rowe; Elizabeth Finger; Rik Vandenberghe; Alexandre de Mendonça; Fabrizio Tagliavini; Isabel Santana; Simon Ducharme; Chris R Butler; Alexander Gerhard; Johannes Levin; Adrian Danek; Markus Otto; Giovanni Frisoni; Roberta Ghidoni; Sandro Sorbi; Isabelle Le Ber; Florence Pasquier; Georgia Peakman; Emily Todd; Martina Bocchetta; Jonathan D Rohrer; Barbara Borroni
Journal:  JAMA Netw Open       Date:  2021-01-04
View more
  2 in total

1.  Mental health care for older adults: recent advances and new directions in clinical practice and research.

Authors:  Charles F Reynolds; Dilip V Jeste; Perminder S Sachdev; Dan G Blazer
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

2.  Sodium selenate as a therapeutic for tauopathies: A hypothesis paper.

Authors:  Roxane Dilcher; Charles B Malpas; Mark Walterfang; Dennis Velakoulis; Terence J O'Brien; Lucy Vivash
Journal:  Front Aging Neurosci       Date:  2022-08-05       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.